Related articles
-
NewsLong-acting therapies continue to gain momentum in HIV, says GlobalData
The next phase of competition in the HIV market will be defined not only by achieving viral suppression, but improving treatment adherence, reducing medication burden and delivering more convenient treatment options, says a new analysis.
-
CareersMember Q&A: Thomas Thompson on the central role AMI has played in his research journey
Pharmacist and microbiologist Dr Thomas Thompson reveals how AMI membership has played a central role in reaching the point where he is about to start building his own research programme in the School of Pharmacy at Queen’s University Belfast.
-
NewsOak leaves harbor distinct microbial worlds on their opposite surfaces
Researchers have discovered that the upper and lower surfaces of a single oak leaf function as two fundamentally different microbial habitats.
More from News
-
-
NewsTriple-dose regimen may permanently clear HIV in infected newborns
New research suggests a one-time regimen of therapies given to newborns within three days of birth could permanently clear HIV infection.
-
NewsNew viral marker strategies improve prediction of functional cure in chronic hepatitis B
Researchers identify how combining classical and emerging viral biomarkers can better predict functional cure and guide individualized hepatitis B treatment.
No comments yet